Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban in elective PCI
NCT00508924Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of argatroban in coronary artery disease (CAD), unstable angina, sponsored by Mitsubishi Tanabe Pharma. Started Aug 2005; status: completed.
02
Drugs
argatroban
03
Conditions
coronary artery disease (CAD)unstable angina
Beyond the preview
Go deeper on NCT00508924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00508924.